肺功能检查的临床应用研究进展
Research Progress of Clinical Application of Pulmonary Function Test
摘要: 肺功能检查(pulmonary function test, PFT)发展由来已久,随着研究的不断深入,PFT的扩展内容得到丰富发展,不仅在慢性阻塞性肺疾病(chronic obstructive pulmonary disease, COPD)、支气管哮喘等常见呼吸系统疾病中具有重要价值,在其他临床实践中也逐渐显现出重要指导意义。但PFT在临床实践中仍存在局限性,当前PFT报告解读标准亟待完善确立,人工智能的辅助判读应用还需进一步探究,PFT的临床应用仍有较大普及和发展空间。
Abstract: The development of pulmonary function tests (PFTs) has a long history, and with the continuous advancement of research, the expanded content of PFTs has been enriched and developed, not only having significant value in common respiratory systems diseases such as chronic obstructive pulmonary disease (COPD) and bronchial asthma, but also gradually showing important guidance significance in other clinical practices. However, there are still limitations in the clinical practice of PFTs, and the current standard for interpreting PFT reports urgently needs to be improved and established. The application of artificial intelligence assisted judgment needs further exploration, and there is still considerable room for the popularization and development of PFT clinical applications.
文章引用:徐美子, 刘丽, 王吉, 胡应雪, 黄志文. 肺功能检查的临床应用研究进展[J]. 临床医学进展, 2025, 15(1): 1533-1543. https://doi.org/10.12677/acm.2025.151205

参考文献

[1] Neder, J.A., de-Torres, J.P., Milne, K.M. and O’Donnell, D.E. (2020) Lung Function Testing in Chronic Obstructive Pulmonary Disease. Clinics in Chest Medicine, 41, 347-366. [Google Scholar] [CrossRef] [PubMed]
[2] Distler, O., Assassi, S., Cottin, V., Cutolo, M., Danoff, S.K., Denton, C.P., et al. (2020) Predictors of Progression in Systemic Sclerosis Patients with Interstitial Lung Disease. European Respiratory Journal, 55, Article 1902026. [Google Scholar] [CrossRef] [PubMed]
[3] Maquet, P. (1989) Borelli: De Motu Animalium. A First Treatise on Biomechanics. Acta Orthopaedica Belgica, 55, 541-546.
[4] Sorensen, J.B., Morris, A.H., Crapo, R.O. and Gardner, R.M. (1980) Selection of the Best Spirometric Values for Interpretation. American Review of Respiratory Disease, 122, 802-805. [Google Scholar] [CrossRef] [PubMed]
[5] Graham, B.L., Steenbruggen, I., Miller, M.R., Barjaktarevic, I.Z., Cooper, B.G., Hall, G.L., et al. (2019) Standardization of Spirometry 2019 Update. an Official American Thoracic Society and European Respiratory Society Technical Statement. American Journal of Respiratory and Critical Care Medicine, 200, e70-e88. [Google Scholar] [CrossRef] [PubMed]
[6] Bhakta, N.R., Mcgowan, A., Ramsey, K.A., et al. (2023) European Respiratory Society/American Thoracic Society Technical Statement: Standardization of the Measurement of Lung Volumes, 2023 Update. The European Respiratory Journal, 62, Article 2201519.
[7] 郑劲平. 中国肺功能联盟介绍[J]. 中国实用内科杂志, 2013, 33(S1): 5-6.
[8] 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第一部分): 概述及一般要求[J]. 中华结核和呼吸杂志, 2014, 37(6): 402-405.
[9] 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第二部分): 肺量计检查[J]. 中华结核和呼吸杂志, 2014, 37(7): 481-486.
[10] 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第三部分): 组织胺和乙酰甲胆碱支气管激发试验[J]. 中华结核和呼吸杂志, 2014, 37(8): 566-571.
[11] 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南(第四部分): 支气管舒张试验[J]. 中华结核和呼吸杂志, 2014, 37(9): 655-658.
[12] 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南: 肺弥散功能测定[J]. 中华结核和呼吸杂志, 2015, 38(3): 164-169.
[13] 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南: 肺容量检查[J]. 中华结核和呼吸杂志, 2015, 38(4): 255-260.
[14] 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南: 体积描记法肺容量和气道阻力检查[J]. 中华结核和呼吸杂志, 2015, 38(5): 342-347.
[15] 中华医学会呼吸病学分会肺功能专业组. 肺功能检查指南: 呼气峰值流量及其变异率检查[J]. 中华结核和呼吸杂志, 2017, 40(6): 426-430.
[16] 梁丽娜, 李允, 郑劲平, 等. 国内指南与2020年ARTP肺功能检查声明的异同解读[J]. 中国循证医学杂志, 2024, 24(4): 445-450.
[17] Menezes, A.M.B., Pérez-Padilla, R., Wehrmeister, F.C., Lopez-Varela, M.V., Muiño, A., Valdivia, G., et al. (2014) FEV1 Is a Better Predictor of Mortality than FVC: The PLATINO Cohort Study. PLOS ONE, 9, e109732. [Google Scholar] [CrossRef] [PubMed]
[18] Fletcher, C. and Peto, R. (1977) The Natural History of Chronic Airflow Obstruction. British Medical Journal, 1, 1645-1648. [Google Scholar] [CrossRef] [PubMed]
[19] Drummond, M.B., Hansel, N.N., Connett, J.E., Scanlon, P.D., Tashkin, D.P. and Wise, R.A. (2012) Spirometric Predictors of Lung Function Decline and Mortality in Early Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 185, 1301-1306. [Google Scholar] [CrossRef] [PubMed]
[20] Venkatesan, P. (2024) GOLD COPD Report: 2024 Update. The Lancet Respiratory Medicine, 12, 15-16. [Google Scholar] [CrossRef] [PubMed]
[21] Finch, D., Lange, P., Halpin, D., O’Donnell, D. and MacNee, W. (2016) Diagnosis, Assessment, and Phenotyping of COPD: Beyond FEV1. International Journal of Chronic Obstructive Pulmonary Disease, 11, 3-12. [Google Scholar] [CrossRef] [PubMed]
[22] 陈典, 隆寰宇, 李姝润, 等. 2024年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2024, 27(13): 1533-1543.
[23] O’Donnell, D.E. (2006) Hyperinflation, Dyspnea, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease. Proceedings of the American Thoracic Society, 3, 180-184. [Google Scholar] [CrossRef] [PubMed]
[24] Balasubramanian, A., MacIntyre, N.R., Henderson, R.J., Jensen, R.L., Kinney, G., Stringer, W.W., et al. (2019) Diffusing Capacity of Carbon Monoxide in Assessment of COPD. Chest, 156, 1111-1119. [Google Scholar] [CrossRef] [PubMed]
[25] Mirsadraee, M., Boskabady, M.H. and Attaran, D. (2013) Diagnosis of Chronic Obstructive Pulmonary Disease Earlier than Current Global Initiative for Obstructive Lung Disease Guidelines Using a Feasible Spirometry Parameter (Maximal-Mid Expiratory Flow/Forced Vital Capacity). Chronic Respiratory Disease, 10, 191-196. [Google Scholar] [CrossRef] [PubMed]
[26] 中华医学会呼吸病学分会哮喘学组. 支气管激发试验临床应用中国专家共识(2024版) [J]. 中华医学杂志, 2024(22): 2031-2040.
[27] Bokov, P. and Delclaux, C. (2016) Interprétation et utilisation des explorations fonctionnelles respiratoires de routine de l’adulte: Spirométrie, volumes non mobilisables, Diffusion, Hématose, Test de provocation bronchique à la métacholine et test de marche. La Revue de Médecine Interne, 37, 100-110. [Google Scholar] [CrossRef] [PubMed]
[28] 于淼, 刘喆, 王颖, 等. 呼出气一氧化氮在哮喘-慢阻肺重叠综合征患者测定的临床意义[J]. 航空航天医学杂志, 2020, 31(6): 700-726.
[29] 潘海洋, 卢立国, 严明月, 等. 慢阻肺急性加重期肺功能与呼出气一氧化氮、血清维生素D、IL-13水平的相关性分析[J]. 临床肺科杂志, 2021, 26(9): 1343-1347.
[30] 彭清. 脉冲震荡技术与肺量计检查在评估小气道功能中的应用[D]: [硕士学位论文]. 长沙: 中南大学, 2022.
[31] Skjørten, I., Hilde, J.M., Melsom, M.N., Hisdal, J., Hansteen, V., Steine, K., et al. (2017) Cardiopulmonary Exercise Test and PaO2 in Evaluation of Pulmonary Hypertension in COPD. International Journal of Chronic Obstructive Pulmonary Disease, 13, 91-100. [Google Scholar] [CrossRef] [PubMed]
[32] Ho, T., Cusack, R.P., Chaudhary, N., Satia, I. and Kurmi, O.P. (2019) Under-and Over-Diagnosis of COPD: A Global Perspective. Breathe, 15, 24-35. [Google Scholar] [CrossRef] [PubMed]
[33] Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R.O., Burgos, F., Casaburi, R., et al. (2005) Interpretative Strategies for Lung Function Tests. European Respiratory Journal, 26, 948-968. [Google Scholar] [CrossRef] [PubMed]
[34] Quanjer, P.H., Pretto, J.J., Brazzale, D.J. and Boros, P.W. (2013) Grading the Severity of Airways Obstruction: New Wine in New Bottles. European Respiratory Journal, 43, 505-512. [Google Scholar] [CrossRef] [PubMed]
[35] Calverley, P.M.A. (2023) A STAR Is Born: A New Approach to Assessing Chronic Obstructive Pulmonary Disease Severity. American Journal of Respiratory and Critical Care Medicine, 208, 647-648. [Google Scholar] [CrossRef] [PubMed]
[36] Balasubramanian, A., Wise, R.A., Stanojevic, S., Miller, M.R. and McCormack, M.C. (2024) FEV1Q: A Race-Neutral Approach to Assessing Lung Function. European Respiratory Journal, 63, Article 2301622. [Google Scholar] [CrossRef] [PubMed]
[37] Casanova, C., Cote, C., de Torres, J.P., Aguirre-Jaime, A., Marin, J.M., Pinto-Plata, V., et al. (2005) Inspiratory-to-Total Lung Capacity Ratio Predicts Mortality in Patients with Chronic Obstructive Pulmonary Disease. American Journal of Respiratory and Critical Care Medicine, 171, 591-597. [Google Scholar] [CrossRef] [PubMed]
[38] Zeng, S., Tham, A., Bos, B., Jin, J., Giang, B. and Arjomandi, M. (2018) Lung Volume Indices Predict Morbidity in Smokers with Preserved Spirometry. Thorax, 74, 114-124. [Google Scholar] [CrossRef] [PubMed]
[39] Shin, T.R., Oh, Y., Park, J.H., Lee, K.S., Oh, S., Kang, D.R., et al. (2015) The Prognostic Value of Residual Volume/Total Lung Capacity in Patients with Chronic Obstructive Pulmonary Disease. Journal of Korean Medical Science, 30, 1459-1465. [Google Scholar] [CrossRef] [PubMed]
[40] Kakavas, S., Kotsiou, O.S., Perlikos, F., Mermiri, M., Mavrovounis, G., Gourgoulianis, K., et al. (2021) Pulmonary Function Testing in COPD: Looking Beyond the Curtain of FEV1. NPJ Primary Care Respiratory Medicine, 31, Article No. 23. [Google Scholar] [CrossRef] [PubMed]
[41] Kim, Y., Kim, S.H., Rhee, C.K., Lee, J.S., Lee, C.Y., Kim, D.K., et al. (2022) Air Trapping and the Risk of COPD Exacerbation: Analysis from Prospective KOCOSS Cohort. Frontiers in Medicine, 9, Article 835069. [Google Scholar] [CrossRef] [PubMed]
[42] de-Torres, J.P., O’Donnell, D.E., Marín, J.M., Cabrera, C., Casanova, C., Marín, M., et al. (2021) Clinical and Prognostic Impact of Low Diffusing Capacity for Carbon Monoxide Values in Patients with Global Initiative for Obstructive Lung Disease I COPD. Chest, 160, 872-878. [Google Scholar] [CrossRef] [PubMed]
[43] Saint-Pierre, M., Ladha, J., Berton, D.C., Reimao, G., Castelli, G., Marillier, M., et al. (2019) Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects with Preserved FEV1/FVC Ratio? Chest, 156, 497-506. [Google Scholar] [CrossRef] [PubMed]
[44] Lopes, A.J. (2019) Advances in Spirometry Testing for Lung Function Analysis. Expert Review of Respiratory Medicine, 13, 559-569. [Google Scholar] [CrossRef] [PubMed]
[45] Alter, P., Orszag, J., Kellerer, C., Kahnert, K., Speicher, T., Watz, H., et al. (2020) Prediction of Air Trapping or Pulmonary Hyperinflation by Forced Spirometry in COPD Patients: Results from Cosyconet. ERJ Open Research, 6, Article 00092-2020. [Google Scholar] [CrossRef] [PubMed]
[46] An, T.J., Rhee, C.K., Park, Y.B., Yoo, K. and Yoon, H.K. (2022) FVC, but Not FEV1, Is Associated with Clinical Outcomes of Asthma-COPD Overlap. Scientific Reports, 12, Article 13820. [Google Scholar] [CrossRef] [PubMed]
[47] Machida, H., Inoue, S., Shibata, Y., Kimura, T., Sato, K., Abe, K., et al. (2021) Thymus and Activation-Regulated Chemokine (TARC/CCL17) Predicts Decline of Pulmonary Function in Patients with Chronic Obstructive Pulmonary Disease. Allergology International, 70, 81-88. [Google Scholar] [CrossRef] [PubMed]
[48] 雷佳慧, 赵丽敏. 全球哮喘防治倡议(GINA) 2024更新要点解读[J]. 中华实用诊断与治疗杂志, 2024, 38(7): 649-655.
[49] Louis, R., Satia, I., Ojanguren, I., Schleich, F., Bonini, M., Tonia, T., et al. (2022) European Respiratory Society Guidelines for the Diagnosis of Asthma in Adults. European Respiratory Journal, 60, Article 2101585. [Google Scholar] [CrossRef] [PubMed]
[50] Korevaar, D.A., Damen, J.A., Heus, P., Moen, M.J., Spijker, R., van Veen, I.H., et al. (2023) Effectiveness of FeNO-Guided Treatment in Adult Asthma Patients: A Systematic Review and Meta-Analysis. Clinical & Experimental Allergy, 53, 798-808. [Google Scholar] [CrossRef] [PubMed]
[51] Escamilla-Gil, J.M., Fernandez-Nieto, M. and Acevedo, N. (2022) Understanding the Cellular Sources of the Fractional Exhaled Nitric Oxide (FeNO) and Its Role as a Biomarker of Type 2 Inflammation in Asthma. BioMed Research International, 2022, Article 5753524. [Google Scholar] [CrossRef] [PubMed]
[52] Ramsey, K.A., Stanojevic, S., Chavez, L., Johnson, N., Bowerman, C., Hall, G.L., et al. (2024) Global Lung Function Initiative Reference Values for Multiple Breath Washout Indices. European Respiratory Journal, 64, Article 2400524. [Google Scholar] [CrossRef] [PubMed]
[53] Yun, H., Eom, S. and Hahn, Y. (2023) Assessing Asthma Control by Impulse Oscillometry and Fractional Expiratory Nitric Oxide in Children with Normal Spirometry. The Journal of Allergy and Clinical Immunology: In Practice, 11, 2822-2829.e1. [Google Scholar] [CrossRef] [PubMed]
[54] Manoharan, A., Anderson, W.J., Lipworth, J. and Lipworth, B.J. (2014) Assessment of Spirometry and Impulse Oscillometry in Relation to Asthma Control. Lung, 193, 47-51. [Google Scholar] [CrossRef] [PubMed]
[55] Galant, S.P. and Morphew, T. (2024) Adding Oscillometry to Spirometry in Guidelines Better Identifies Uncontrolled Asthma, Future Exacerbations, and Potential Targeted Therapy. Annals of Allergy, Asthma & Immunology, 132, 21-29. [Google Scholar] [CrossRef] [PubMed]
[56] Grell, A.V., Vera, R.G., Yarur, A.M., Castro-Rodriguez, J.A., Montenegro, M.A.P., Colodro, O.F., et al. (2023) Impulse Oscillometry in Preschool Children with Persistent Asthma Can Predict Spirometry at School Age. Pediatric Pulmonology, 58, 1411-1416. [Google Scholar] [CrossRef] [PubMed]
[57] Lee, H., Kim, S.Y., Park, Y.S., Choi, S.M., Lee, J.H. and Park, J. (2024) Prognostic Implication of 1-Year Decline in Diffusing Capacity in Newly Diagnosed Idiopathic Pulmonary Fibrosis. Scientific Reports, 14, Article No. 8857. [Google Scholar] [CrossRef] [PubMed]
[58] Maher, T.M. (2024) Interstitial Lung Disease. Journal of the American Medical Association, 331, Article 1655. [Google Scholar] [CrossRef] [PubMed]
[59] Kim, J.S., Murray, S., Yow, E., Anstrom, K.J., Kim, H.J., Flaherty, K.R., et al. (2024) Comparison of Pirfenidone and Nintedanib. Chest, 165, 1163-1173. [Google Scholar] [CrossRef] [PubMed]
[60] Wang, X., Wang, M., Qiu, H., Yu, I. and Yano, E. (2010) Longitudinal Changes in Pulmonary Function of Asbestos Workers. Journal of Occupational Health, 52, 272-277. [Google Scholar] [CrossRef] [PubMed]
[61] Barnikel, M., Million, P.M., Knoop, H. and Behr, J. (2019) The Natural Course of Lung Function Decline in Asbestos Exposed Subjects with Pleural Plaques and Asbestosis. Respiratory Medicine, 154, 82-85. [Google Scholar] [CrossRef] [PubMed]
[62] Yang, X.L., Zhu, X.L., Li, A., et al. (2016) Characteristics of Lung Function in Patients with Asbestosis of Different Stages. Chinese Journal of Industrial Hygiene and Occupational Diseases, 34, 687-690.
[63] Chung, K.F. and Pavord, I.D. (2008) Prevalence, Pathogenesis, and Causes of Chronic Cough. The Lancet, 371, 1364-1374. [Google Scholar] [CrossRef] [PubMed]
[64] Sadeghi, M.H. and Morice, A.H. (2017) The Emerging Role of the Eosinophil and Its Measurement in Chronic Cough. The Open Respiratory Medicine Journal, 11, 17-30. [Google Scholar] [CrossRef] [PubMed]
[65] 中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 中国咳嗽基层诊疗与管理指南(2024年) [J]. 中华全科医师杂志, 2024, 23(8): 793-812.
[66] 梁松倩. FeNO联合肺功能检测对慢性咳嗽病因诊断的价值[D]: [硕士学位论文]. 太原: 山西医科大学, 2023.
[67] 殷军民, 刘麒彦, 花梅娟, 等. 肺功能联合呼出气一氧化氮测定在儿童慢性咳嗽中的价值分析[J]. 系统医学, 2023, 8(14): 14-16.
[68] 屈平. 呼出气一氧化氮与肺功能联合检测用于慢性咳嗽的诊断价值[J]. 中国社区医师, 2022, 38(25): 79-81.
[69] 丁金盾, 邱章伟, 徐晓婷, 等. 呼出气一氧化氮与小气道功能预测咳嗽变异性哮喘患者支气管高反应性[J]. 临床肺科杂志, 2022, 27(2): 169-173.
[70] Budhwar, N. and Syed, Z. (2020) Chronic Dyspnea: Diagnosis and Evaluation. American Family Physician, 101, 542-548.
[71] Stoller, J.K. (1992) Spirometry: A Key Diagnostic Test in Pulmonary Medicine. Cleveland Clinic Journal of Medicine, 59, 75-78. [Google Scholar] [CrossRef] [PubMed]
[72] Wimalaratna, H.S.K., Farrell, J. and Lee, H.Y. (1989) Measurement of Diffusing Capacity in Pulmonary Embolism. Respiratory Medicine, 83, 481-485. [Google Scholar] [CrossRef] [PubMed]
[73] Bastas, D., Brandão, L.R., Vincelli, J., Wilson, D., Perrem, L., Guerra, V., et al. (2024) Long-Term Outcomes of Pulmonary Embolism in Children and Adolescents. Blood, 143, 631-640. [Google Scholar] [CrossRef] [PubMed]
[74] 陈荣, 孙兴国, 张也, 等. 重症心力衰竭患者运动病理生理学特征的临床研究[J]. 中国应用生理学杂志, 2021, 37(2): 162-168.
[75] Izadi, S., Esmaili, S., Emami, S., Izadi, S., Eskandari, M., Yadollahzadeh, M., et al. (2022) Association between DLCO Index and the Severity of Heart Failure: A Cross-Sectional Study. Acta Cardiologica, 78, 250-255. [Google Scholar] [CrossRef] [PubMed]
[76] 中国医师协会呼吸医师分会肺功能与临床呼吸生理工作委员会, 中华医学会呼吸病学分会肺功能学组, 中国老年医学会呼吸分会肺功能学组. 肺功能检查技术规范——脉冲振荡技术检查[J]. 中华结核和呼吸杂志, 2022, 45(10): 960-969.
[77] 金兵, 朱述阳, 陈碧, 等. 脉冲振荡肺功能在鉴别慢性阻塞性肺疾病急性加重期和慢性心力衰竭所致呼吸困难的价值[J]. 江苏医药, 2014, 40(15): 1788-1790.
[78] Parshall, M.B., Schwartzstein, R.M., Adams, L., Banzett, R.B., Manning, H.L., Bourbeau, J., et al. (2012) An Official American Thoracic Society Statement: Update on the Mechanisms, Assessment, and Management of Dyspnea. American Journal of Respiratory and Critical Care Medicine, 185, 435-452. [Google Scholar] [CrossRef] [PubMed]
[79] British Thoracic Society, (2001) Guidelines on the Selection of Patients with Lung Cancer for Surgery. Thorax, 56, 89-108. [Google Scholar] [CrossRef] [PubMed]
[80] Colice, G.L., Shafazand, S., Griffin, J.P., Keenan, R. and Bolliger, C.T. (2007) Physiologic Evaluation of the Patient with Lung Cancer Being Considered for Resectional Surgery. Chest, 132, 161S-177S. [Google Scholar] [CrossRef] [PubMed]
[81] Li, W., Zhao, J., Gong, C., Zhou, R., Yan, D., Ruan, H., et al. (2024) Value of Preoperative Evaluation of FEV1 in Patients with Destroyed Lung Undergoing Pneumonectomy—A 20-Year Real-World Study. BMC Pulmonary Medicine, 24, Article No. 39. [Google Scholar] [CrossRef] [PubMed]
[82] Mariel, M., Gabor, A. and Koichi, Y. (2022) The Role of Pulmonary Function Test in Perioperative Management of Patients with Cystic Fibrosis. Translational Perioperative and Pain Medicine, 9, 438-444. [Google Scholar] [CrossRef
[83] Hsieh, M., Lee, W., Cho, H., Wu, M., Hu, H., Kao, K., et al. (2018) Recovery of Pulmonary Functions, Exercise Capacity, and Quality of Life after Pulmonary Rehabilitation in Survivors of ARDS Due to Severe Influenza a (H1N1) Pneumonitis. Influenza and Other Respiratory Viruses, 12, 643-648. [Google Scholar] [CrossRef] [PubMed]
[84] Malinczak, C., Fonseca, W., Hrycaj, S.M., Morris, S.B., Rasky, A.J., Yagi, K., et al. (2024) Early-Life Pulmonary Viral Infection Leads to Long-Term Functional and Lower Airway Structural Changes in the Lungs. American Journal of Physiology-Lung Cellular and Molecular Physiology, 326, L280-L291. [Google Scholar] [CrossRef] [PubMed]
[85] Cho, O., Oh, Y., Chun, M., Noh, O.K. and Heo, J. (2018) Prognostic Implication of FEV1/FVC Ratio for Limited-Stage Small Cell Lung Cancer. Journal of Thoracic Disease, 10, 1797-1805. [Google Scholar] [CrossRef] [PubMed]
[86] Kang, H.S., Shin, A.Y., Yeo, C.D., Kim, J.S., Kim, Y.H., Kim, J.W., et al. (2018) A Lower Level of Forced Expiratory Volume in One Second Predicts the Poor Prognosis of Small Cell Lung Cancer. Journal of Thoracic Disease, 10, 2179-2185. [Google Scholar] [CrossRef] [PubMed]
[87] Kahnert, K., Lempert, L.M., Behr, J., Elsner, L., Bolt, T., Tufman, A., et al. (2023) Hyperinflation and Reduced Diffusing Capacity Predict Prognosis in SCLC: Value of Extended Pre-Therapeutic Lung Function Testing. Therapeutic Advances in Respiratory Disease, 17, Article 1611188298. [Google Scholar] [CrossRef] [PubMed]
[88] Martinez, F.J., Criner, G.J., Gessner, C., Jandl, M., Scherbovsky, F., Shinkai, M., et al. (2023) Icenticaftor, a CFTR Potentiator, in COPD: A Multicenter, Parallel-Group, Double-Blind Clinical Trial. American Journal of Respiratory and Critical Care Medicine, 208, 417-427. [Google Scholar] [CrossRef] [PubMed]
[89] Casanova, C., de Torres, J.P., Aguirre-Jaíme, A., Pinto-Plata, V., Marin, J.M., Cordoba, E., et al. (2011) The Progression of Chronic Obstructive Pulmonary Disease Is Heterogeneous. American Journal of Respiratory and Critical Care Medicine, 184, 1015-1021. [Google Scholar] [CrossRef] [PubMed]
[90] Lange, P., Celli, B., Agustí, A., Boje Jensen, G., Divo, M., Faner, R., et al. (2015) Lung-Function Trajectories Leading to Chronic Obstructive Pulmonary Disease. New England Journal of Medicine, 373, 111-122. [Google Scholar] [CrossRef] [PubMed]
[91] Zhang, X., Gray, A.R. and Hancox, R.J. (2024) Predictors of Lung Function in Early Adulthood: A Population-Based Cohort Study. Respirology, 29, 897-904. [Google Scholar] [CrossRef] [PubMed]
[92] Lim, S., Lam, D.C., Muttalif, A.R., Yunus, F., Wongtim, S., Lan, L.T.T., et al. (2015) Impact of Chronic Obstructive Pulmonary Disease (COPD) in the Asia-Pacific Region: The EPIC Asia Population-Based Survey. Asia Pacific Family Medicine, 14, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
[93] Kim, C., Yoo, K.H., Rhee, C.K., Yoon, H.K., Kim, Y.S., Lee, S.W., et al. (2014) Health Care Use and Economic Burden of Patients with Diagnosed Chronic Obstructive Pulmonary Disease in Korea. The International Journal of Tuberculosis and Lung Disease, 18, 737-743. [Google Scholar] [CrossRef] [PubMed]
[94] Wang, C., Xu, J., Yang, L., Xu, Y., Zhang, X., Bai, C., et al. (2018) Prevalence and Risk Factors of Chronic Obstructive Pulmonary Disease in China (The China Pulmonary Health [CPH] Study): A National Cross-Sectional Study. The Lancet, 391, 1706-1717. [Google Scholar] [CrossRef] [PubMed]
[95] Tong, H., Cong, S., Fang, L.W., et al. (2023) Performance of Pulmonary Function Test in People Aged 40 Years and above in China, 2019-2020. Chinese Journal of Epidemiology, 44, 727-734.
[96] Peng, B., Zhang, X., Jiang, X., et al. (2022) The Availability of Essential Medicines and Diagnostic Devices for Chronic Obstructive Pulmonary Disease in Primary Care. Chinese General Practice, 25, 771-781.
[97] Liu, R., Jia, C. and Zhang, C. (2021) Investigation and Analysis of the Allocation of Medical Resources Related to Chronic Obstructive Pulmonary Disease in Primary Medical Institutions. Chinese Hospital Management, 41, 43-46.
[98] Lei, J., Huang, K., Wu, S., Xu, J., Xu, Y., Zhao, J., et al. (2024) Heterogeneities and Impact Profiles of Early Chronic Obstructive Pulmonary Disease Status: Findings from the China Pulmonary Health Study. The Lancet Regional HealthWestern Pacific, 45, Article 101021. [Google Scholar] [CrossRef] [PubMed]
[99] 傅唯佳, 汤梁峰, 叶成杰, 等. 运用人工智能技术进行肺功能数据库构建并辅助诊断实践[J]. 中国医疗器械信息, 2022, 28(14): 147-150.
[100] 郭静, 陶莲德, 闫祥云, 等. 机器学习在慢性阻塞性肺疾病中的研究进展[J]. 四川医学, 2024, 45(11): 1272-1276.
[101] 汪哲宇. 数字化慢病管理系统的研究与实践[D]: [博士学位论文]. 杭州: 浙江大学, 2021.
[102] Silvestre, O.M., Nadruz, W., Querejeta Roca, G., Claggett, B., Solomon, S.D., Mirabelli, M.C., et al. (2018) Declining Lung Function and Cardiovascular Risk. Journal of the American College of Cardiology, 72, 1109-1122. [Google Scholar] [CrossRef] [PubMed]
[103] Cheng, Y., Chen, Z., Yao, F., Liu, L., Zhang, M. and Wu, S. (2021) Airflow Obstruction, Impaired Lung Function and Risk of Sudden Cardiac Death: A Prospective Cohort Study. Thorax, 77, 652-662. [Google Scholar] [CrossRef] [PubMed]
[104] Lee, T.Y. and Sadatsafavi, M. (2023) Lung Function as Independent Predictor of Cardiovascular Disease Risk: Implications for Practice and Policy. Thorax, 79, 196-197. [Google Scholar] [CrossRef] [PubMed]
[105] Zhang, R., Zhou, J., Cai, Y., Shu, L., Simó, R. and Lecube, A. (2020) Non-Linear Association between Diabetes Mellitus and Pulmonary Function: A Population-Based Study. Respiratory Research, 21, Article No. 292. [Google Scholar] [CrossRef] [PubMed]
[106] de Carvalho, M., Fernandes, S.R., Pereira, M., Gromicho, M., Santos, M.O., Alves, I., et al. (2022) Respiratory Function Tests in Amyotrophic Lateral Sclerosis: The Role of Maximal Voluntary Ventilation. Journal of the Neurological Sciences, 434, Article 120143. [Google Scholar] [CrossRef] [PubMed]
[107] Shrestha, S., Zhu, X., London, S.J., Sullivan, K.J., Lutsey, P.L., Windham, B.G., et al. (2023) Association of Lung Function with Cognitive Decline and Incident Dementia in the Atherosclerosis Risk in Communities Study. American Journal of Epidemiology, 192, 1637-1646. [Google Scholar] [CrossRef] [PubMed]